A sequential design to estimate sensitivity and specificity of a diagnostic or screening test
暂无分享,去创建一个
[1] Roseanne McNamee,et al. Optimal designs of two‐stage studies for estimation of sensitivity, specificity and positive predictive value , 2002, Statistics in medicine.
[2] A two-stage validation study for determining sensitivity and specificity. , 1994, Environmental health perspectives.
[3] B. Turnbull,et al. Group Sequential Methods with Applications to Clinical Trials , 1999 .
[4] R A Greenes,et al. Assessment of diagnostic tests when disease verification is subject to selection bias. , 1983, Biometrics.
[5] J M Simpson,et al. Efficient study designs to assess the accuracy of screening tests. , 1994, American journal of epidemiology.
[6] M. Lederman,et al. Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. , 1999, AIDS.
[7] S. Pocock,et al. Stopping rules and estimation problems in clinical trials. , 1988, Statistics in medicine.
[8] John Whitehead,et al. On the bias of maximum likelihood estimation following a sequential test , 1986 .
[9] A. Tenenbein. A Double Sampling Scheme for Estimating from Binomial Data with Misclassifications , 1970 .
[10] J. Whitehead. Supplementary analysis at the conclusion of a sequential clinical trial. , 1986, Biometrics.
[11] J. Kaldor,et al. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. , 1999, AIDS.
[12] Xiao-Hua Zhou,et al. Maximum likelihood estimators of sensitivity and specificity corrected for verification bias , 1993 .
[13] Xiao-Hua Zhou,et al. Prospective studies of diagnostic test accuracy when disease prevalence is low. , 2002, Biostatistics.